scispace - formally typeset
W

Willard M. Daggett

Researcher at Harvard University

Publications -  184
Citations -  8627

Willard M. Daggett is an academic researcher from Harvard University. The author has contributed to research in topics: Myocardial infarction & Coronary artery disease. The author has an hindex of 55, co-authored 184 publications receiving 8492 citations. Previous affiliations of Willard M. Daggett include Albany Medical College & St Vincent Hospital.

Papers
More filters
Journal ArticleDOI

Cardiovascular Response to Large Doses of Intravenous Morphine in Man

TL;DR: In the cardiac but not in the normal subjects, significant increases in cardiac index, stroke index, central venous pressure, and pulmonary-artery pressure were observed after morphine was administered, suggesting that large doses of morphine may be used with safety in patients with minimal circulatory reserve.
Journal ArticleDOI

Ventricular septal rupture: a review of clinical and physiologic features and an analysis of survival.

TL;DR: It is suggested that shock was produced mainly by right ventricular impairment in patients with postinfarction ventricular septal rupture, and that perioperative survival was much higher in patients who did not have shock preoperatively than in those who did.
Journal ArticleDOI

Cardiac Operations in Patients 80 Years Old and Older

TL;DR: Cardiac operations are successful in most octogenarians with increased hospital mortality, postoperative stroke, and longer hospital stay, but long-term survival is largely determined by concurrent medical diseases.
Journal ArticleDOI

Surgery for Post-Myocardial Infarct Ventricular Septal Defect

TL;DR: Clinical deterioration, once begun, progressed rapidly, and could be reversed only temporarily by intra-aortic balloon pumping, used in 26 patients for safe conduct of cardiac catheterization and for peri-operative hemodynamic support.
Journal ArticleDOI

Acute traumatic disruption of the thoracic aorta: a ten-year experience.

TL;DR: Immediate operative intervention with a heparinized shunt is preferable as soon as the diagnosis of thoracic aortic disruption has been established, but elective delay of operation in patients with severe concomitant injuries can be achieved safely with beta blockade and antihypertensive therapy.